• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I期和II期睾丸精原细胞瘤睾丸切除术后放射治疗的长期结果。

Long-term outcome of postorchiectomy radiation therapy for stage I and II testicular seminoma.

作者信息

Akimoto T, Takahashi I, Takahashi M, Yamakawa M, Hayakawa K, Mitsuhashi N, Niibe H

机构信息

Department of Radiology and Radiation Oncology, Gunma University School of Medicine, Japan.

出版信息

Anticancer Res. 1997 Sep-Oct;17(5B):3781-5.

PMID:9427780
Abstract

To evaluate the treatment-related late sequelae including gonadal function and second malignancy 94 patients with stage I and II testicular seminoma treated with postorchiectomy radiation therapy were analyzed retrospectively. The 10-year cause specific, disease free and actuarial survival rates were 100, 98.5 and 96.1% for stage II and 91.7, 83.3 and 91.7% for stage II, respectively. The most common late sequelae of gastrointestinal tract was peptic ulcer, developing in 16% of all patients with a median interval of 12 months, but severity was mild except one who needed subtotal gastrectomy. Second malignancies developed in 9 patients (9.5%) with a median interval of 13 years, but calculated O/E ratio excluding 2 patients with secondary germ cell tumor of contralateral testis was 2.3 and did not reach a significant level statistically. Concerning gonadal function assessed from the number of the children, 79% of the patients who wanted to have children after the treatment were successful in fathering children. No fatal complications were observed.

摘要

为评估包括性腺功能和第二原发恶性肿瘤在内的与治疗相关的晚期后遗症,我们对94例接受睾丸切除术后放射治疗的Ⅰ期和Ⅱ期睾丸精原细胞瘤患者进行了回顾性分析。Ⅱ期患者的10年病因特异性生存率、无病生存率和精算生存率分别为100%、98.5%和96.1%,Ⅰ期患者分别为91.7%、83.3%和91.7%。胃肠道最常见的晚期后遗症是消化性溃疡,在所有患者中的发生率为16%,中位间隔时间为12个月,但除1例需要行胃大部切除术的患者外,严重程度均较轻。9例患者(9.5%)发生了第二原发恶性肿瘤,中位间隔时间为13年,但排除2例对侧睾丸继发性生殖细胞肿瘤患者后计算的观察/预期比值为2.3,未达到统计学显著水平。从生育子女数量评估性腺功能,79%希望在治疗后生育的患者成功育有子女。未观察到致命并发症。

相似文献

1
Long-term outcome of postorchiectomy radiation therapy for stage I and II testicular seminoma.I期和II期睾丸精原细胞瘤睾丸切除术后放射治疗的长期结果。
Anticancer Res. 1997 Sep-Oct;17(5B):3781-5.
2
Results of radiotherapy for 230 patients with stage I-II seminomas.230例I-II期精原细胞瘤患者的放疗结果。
Strahlenther Onkol. 1996 Apr;172(4):186-92.
3
Secondary malignancy among seminoma patients treated with adjuvant radiation therapy.接受辅助放疗的精原细胞瘤患者中的继发性恶性肿瘤。
Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):831-5. doi: 10.1016/0360-3016(95)00200-8.
4
Radiotherapy for stage I and II testicular seminoma after orchidectomy.睾丸切除术后I期和II期睾丸精原细胞瘤的放射治疗。
S Afr J Surg. 1996 May;34(2):95-8.
5
Mortality after cure of testicular seminoma.睾丸精原细胞瘤治愈后的死亡率。
J Clin Oncol. 2004 Feb 15;22(4):640-7. doi: 10.1200/JCO.2004.05.205. Epub 2004 Jan 15.
6
Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.I期睾丸精原细胞瘤睾丸切除术后监测的长期结果
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):736-40. doi: 10.1016/j.ijrobp.2004.06.209.
7
[Treatment of stage I pure seminoma of the testis, value of prophylactic radiotherapy].[睾丸I期纯精原细胞瘤的治疗,预防性放疗的价值]
Bull Cancer Radiother. 1994;81(1):53-5.
8
Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.Ⅱ期睾丸精原细胞瘤放疗的长期疗效——梅奥诊所经验
Urol Oncol. 2013 Nov;31(8):1832-8. doi: 10.1016/j.urolonc.2012.03.010. Epub 2012 Apr 25.
9
Long-term outcome of stage I seminoma.I期精原细胞瘤的长期预后
Am J Clin Oncol. 2007 Apr;30(2):205-10. doi: 10.1097/01.coc.0000255613.72254.31.
10
Second primary cancer in irradiated stage I testicular seminoma.放射治疗的Ⅰ期睾丸精原细胞瘤发生的第二原发性癌症。
Strahlenther Onkol. 1993 Nov;169(11):672-7.